IceCure Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-14.49	-14.65	-16.98	-9.9	-3.73	-4.55
Depreciation & Amortization	0.33	0.32	0.25	0.13	0.06	0.03
Share-Based Compensation	1.2	1.31	1.87	0.32	0.23	0.37
Other Operating Activities	0.53	0.5	0.57	-3.15	-0.25	2.16
Operating Cash Flow	-12.44	-12.52	-14.29	-12.61	-3.69	-1.99
Capital Expenditures	-0.26	-0.48	-0.89	-0.53	-0.22	-0.1
Change in Investments	15.16	-0.23	0	4.33	-4.45	0
Investing Cash Flow	14.9	-0.71	-0.89	3.79	-4.67	-0.1
Share Issuance / Repurchase	-	0.08	13.58	30.89	5.86	3.31
Other Financing Activities	2.92	-	0	-	-	-
Financing Cash Flow	2.92	0.08	13.58	30.89	5.86	3.31
Exchange Rate Effect	-0.01	0.03	-0.36	0.04	0.22	0.36
Net Cash Flow	5.38	-13.15	-1.61	22.08	-2.5	1.22
Free Cash Flow	-12.69	-13	-15.18	-13.14	-3.91	-2.09
Free Cash Flow Margin	-389.15%	-402.63%	-492.16%	-317.50%	-101.16%	-128.58%
Free Cash Flow Per Share	-0.27	-0.28	-0.41	-0.46	-0.23	-0.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).